• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Novella Clinical announces new leadership roles

Novella Clinical announces new leadership roles

September 10, 2013
CenterWatch Staff

Three senior executives of CRO Novella Clinical have assumed new leadership roles within the organization.

Deborah Turunjian has been named vice president, oncology clinical development and will lead further expansion of Novella's oncology division. Jamie Gault has been promoted to global head of regulatory affairs and will oversee preparation of regulatory packages for agencies globally. Kathleen Zajd has been named vice president, global quality and compliance.

Turunjian was executive leadership for Novella's business optimization and vendor management departments in addition to her oversight of western U.S. business operations. Turunjian brings over 30 years of leadership experience in business operations, overseeing global outsourcing and strategic partnerships in more than 25 countries. She has more than 10 years of operational management experience of phase I, II and III global oncology trials at both sponsors and CROs. Prior to Novella, Turunjian was director of clinical operations for OSI Pharmaceuticals.

Gault has 25 years experience in regulatory roles both at sponsors and CROs. Her regulatory authority interactions span drugs, biologics, cell and tissue-based products, combination products and medical devices. She has managed regulatory submissions including INDs, IDEs, NDAs and 510(k)s.

Zajd became a part of the Novella senior management team as a result of Novella's acquisition of Prologue Research International in 2010. Prior to co-founding Prologue, Zajd held leadership roles in clinical operations, regulatory and quality with experience spanning more than 25 years across both service organizations and sponsors. She has knowledge of GCPs/GLPs, ICH requirements and international directives/laws that govern the conduct of global clinical trials. With widespread experience conducting and managing domestic and international audit programs, she has also successfully established and maintained corporate quality management systems. 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing